Hudson Bay Capital Management LP Bio Xcel Therapeutics, Inc. Transaction History

Hudson Bay Capital Management LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$6.39 - $28.58 $187,227 - $837,394	29,300 New	29,300 $195,000
Q1 2022 May 16, 2022	SELL	$15.0 - $22.83 $150,000 - $228,299	-10,000 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$20.12 - $35.09 $503,000 - $877,250	-25,000 Reduced 71.43%	10,000 $203,000
Q3 2021 Nov 15, 2021	SELL	$23.84 - $32.03 $119,200 - $160,150	-5,000 Reduced 12.5%	35,000 $1.06 Million
Q2 2021 Aug 16, 2021	BUY	$29.06 - $38.83 $1.16 Million - $1.55 Million	40,000 New	40,000 $1.16 Million

3.14M

22.2K

40.2K

Ticker BTAI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,022,500
Market Cap $12.6M
Description
BioXcel Therapeutics, Inc. is a commercial-stage biopharmaceutical company utilizing artificial intelligence approaches to develop transformative medicines in neuroscience and immuno-oncology. The company's drug re-innovation approach leverages existing approved drugs and/or clinically validated product candidates together with big data and prop...

Get notified when there are updates to the investment portfolio of Hudson Bay Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Hudson Bay Capital Management LP with notifications on news.